Objectives To review the pathophysiology, co-morbidities, and therapeutic options for
psoriasis, psoriatic arthritis and rheumatoid arthritis in order to further understand the …

Psoriasis and psoriatic arthritis (PsA) are chronic immune-mediated diseases that primarily
affect the skin and joints, respectively; these diseases are also associated with high rates of …

Psoriasis is a chronic skin disorder affecting approximately 1% to 3% of the world's
population. A considerable proportion of patients with psoriasis will develop a form of …

Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis that can lead to
decreased health-related quality of life and permanent joint damage leading to functional …

Psoriatic arthritis is a chronic inflammatory joint disease occurring in a subgroup of patients
suffering from psoriasis. This article gives an overview of the complexity of psoriatic arthritis …

Psoriatic arthritis is an inflammatory joint disease that is heterogeneous in presentation and
clinical course. Evidence that this disease is distinct from rheumatoid arthritis and other …

Psoriasis is a lifelong skin disease, affecting about 2% of the global population. Generalized
involvement of the body (erythroderma), extensive pustular lesions, and an associated …

Epidemiological studies have shown that, in psoriasis patients, associated disorders may
occur more frequently than expected. Such comorbidities include psoriatic arthritis, psoriatic …

Psoriasis is a prevalent, chronic inflammatory disease of the skin, mediated by crosstalk
between epidermal keratinocytes, dermal vascular cells, and immunocytes such as antigen …

Psoriatic arthritis occurs in a subset of psoriasis patients and is therefore commonly
encountered in dermatology practice. Although its exact pathogenesis is unknown, psoriatic …